Issue 63, 2020

A portable point-of-care testing system to diagnose lung cancer through the detection of exosomal miRNA in urine and saliva

Abstract

A lung cancer diagnostic kit (LCDK) with the advantages of low cost, easy operation and high sensitivity for the rapid diagnosis of lung cancer was developed. The proposed LCDK is able to noninvasively discriminate lung cancer using clinical salivary and urine samples in a short period of time.

Graphical abstract: A portable point-of-care testing system to diagnose lung cancer through the detection of exosomal miRNA in urine and saliva

Supplementary files

Article information

Article type
Communication
Submitted
03 May 2020
Accepted
24 Jun 2020
First published
29 Jun 2020

Chem. Commun., 2020,56, 8968-8971

A portable point-of-care testing system to diagnose lung cancer through the detection of exosomal miRNA in urine and saliva

P. Zhou, F. Lu, J. Wang, K. Wang, B. Liu, N. Li and B. Tang, Chem. Commun., 2020, 56, 8968 DOI: 10.1039/D0CC03180A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements